Metoject® PEN

Methotrexate 50 mg/ml

Therapeutic Indication:

Metoject® PEN is indicated for the treatment of:

  • Active rheumatoid arthritis in adult patients.
  • Polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
  • Moderate to severe psoriasis in adult patients who are candidates for systemic therapy, and severe psoriatic arthritis in adults.
  • Mild to moderate Crohn’s disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.


  • Composition: Methotrexate 50 mg/ml.
  • Pharmaceutical Form: Solution for Injection.
  • Method of Administration: Subcutaneous.
  • How Supplied: Prefilled Syringe/Pen.
  • Manufacturer: Medac GmbH, Germany.

Contact Us

Contact us today to find out more about our services and discuss your enquiries.